Introduction and ObjectiveAcute kidney injury is the result of many potential factors: acute obstructive uropathy, nephrotoxic medications, hypovolemia, urosepsis, intrinsic factors such as glomerulonephritis, acute tubular necrosis or renal surgery and post obstructive causes such as benign prostatic hyperplasia, calculus disease or obstruction. Partial nephrectomy for renal cell carcinoma usually involves temporarily clamping the renal artery, rendering the kidney ischemic during tumor resection. While decreasing hemorrhage and improving visualization of the resection site, the tradeoff is exposing the kidney to effects of warm ischemia and reperfusion injury. Currently, predominate methods of assessing global renal function include measuring serum creatinine and in turn, estimating glomular filtration rate. In a patient with a normal contralateral kidney, serum creatinine measurement may appear normal due to systemic measurements.Urinary cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) represent potential early biomarkers of acute kidney injury. Our hypothesis was to first determine if urinary cystatin C and NGAL levels can quantitate renal damage secondary to warm ischemia through experiments on in a solitary kidney animal model. A second goal was to investigate use of allopurinol for renoprotective abilities in this same animal model, using cystatin C and NGAL findings to quantify the protective effects.Finally, we evaluated the clinical utility of cystatin C in a clinical series of patients who underwent robotic partial nephrectomy. Our hypothesis was that cystatin C could be used as a clinical biomarker following surgery to assess acute kidney injury post operatively. Unfortunately, our hospital lab does not have the ability to quantitate NGAL levels, and thus only Cystatin C was studied in our surgical population.